Monday, May 9, 2016

Clinical Practice Guidelines (Philippines, 2016): Community Acquired Pneumonia

Diagnosis, Empiric Management and Prevention of Community-Acquired Pneumonia in Immunocompetent Adults.2016.Treatment

This document can be downloaded from: http://philchest.org/v3/wp-content/uploads/2013/05/CAP-Guidelines.pdf

philchest.org is the website of the Philippines College of Chest Physicians (PCCP)

The President of PCCP is: Dr Vincent Balanag

For an overview of PCCP please download the presentation at: http://philchest.org/about-pccp/

The cover page indicates that this document is a joint statement from: PSMID, PCCP, PAFP and PCR

For low risk community acquired pneumonia, AMOXICILLIN remains the standard drug of choice and the use of extended macrolides may also be considered.

Pneumonia is one of the leading causes of morbidity and mortality in the Philippines

The Philippines has over 100 million people and pneumonia is still considered as the leading cause of morbidity and mortality in the Philippines

This blog is dedicated to highlight information (historical and current) on pneumonia in the Philippines.

Please do send us emails if you have any pertinent information to contribute regarding pneumonia in the Philippines.  We will also try to have patients share their experience with pneumonia (history, diagnosis, treatment, therapy and recovery).